{"data":{"issuanceinfo":{"industrycode":"204005","industry":"醫療保健","ipoprice":{"ceiling":"38.700","floor":"32.100"},"ipodate":{"start":"2015-11-10 00:00:00","end":"2015-11-13 00:00:00"},"minimumcapital":"3909.00","subscribed":"125.30","marketcap":"27.24億","H_marketcap":"6.81億","pe":"42.50","codesrate":"100.00","link":"https://staticpdf.iqdii.com/stockdata/notice/Prospectus/02120/LTN20151110008_C.pdf","ipopricing":"38.700","resultdate":"2015-11-19 00:00:00","enddate":"2015-11-13 00:00:00","listeddate":"2015-11-20 00:00:00","issuenumber":"1760.00萬","issuenumberhK":"880.00萬","issuenumberother":"880.00萬","grayprice":"42.55","sponsors":"花旗環球金融亞洲有限公司,中信里昂證券資本市場有限公司","raisemoney":"55520.00萬","use":"1、約50%或305.6百萬港元將用于通過我們多元化的擴張模式在精神科醫療服務供不應求的地區擴張及提升我們的醫療機構網絡及包括我們現有及未來發展中的機構在內的運營能力；\n2、約25%或152.8百萬港元將用于溫州康寧醫院的改造及升級項目，以擴張其運營規模及高端醫療服務能力；\n3、約10%或61.1百萬港元將用于科研、教學及人員培訓用途，包括擴大我們與經挑選的國內外精神科醫療機構及大學的合作；\n4、約8%或48.9百萬港元將用于發展我們的移動和在線醫療咨詢平臺并改進我們的信息科技基礎設施，而我們相信這將進一步提升我們的品牌知名度及患者覆蓋能力；\n5、約7%或42.8百萬港元將用作營運資金及其他一般企業用途。","shares":100,"leadagent":"花旗環球金融亞洲有限公司,花旗環球金融亞洲有限公司,中信里昂證券有限公司","bookrunners":"花旗環球金融亞洲有限公司,花旗環球金融亞洲有限公司,中信里昂證券有限公司","coordinator":"花旗環球金融亞洲有限公司,中信里昂證券有限公司","firstDayOpen":"44.00","IsEiio":0,"Interestdays":6,"PENote":"按經審核的最近年度公司股東應占溢利和發行后總股本計算；發行價未確定時，按招股價中間價計算；發行價確定后，按招股定價計算。","OverAllotment":"有","StabilizingManager":"花旗環球金融亞洲有限公司","code":"E02120","name":"康寧醫院","fullname":"溫州康寧醫院股份有限公司"},"institutioninfo":{"principaloffice":"中國浙江省溫州市黃龍住宅區盛錦路","registrars":"香港中央證券登記有限公司","registrarstel":"(852) 2862 8628","chairman":"管偉立","secretary":"吳詠珊,王健","telephone":"(86577) 8878 9117","substantialshareholders":"管偉立(30.32%),Guangzhou GL Capital Investment Fund L.P.(21.06%),CDH Huatai Investment Management (Beijing) Co., Ltd.(8.91%),王紅月(7.57%)","principalactivities":"於中國從事經營精神科醫院、提供醫院管理服務，以及從事房地產業務。","website":"http://www.knhosp.cn"},"managerinfo":[],"investorinfo":[{"institutionname":"OrbiMed Funds","shareholding":"3,604,900.0","percentage":5.1,"ReleaseDate":"2016-05-20 00:00:00","relatedparty":"OrbiMed Capital LLC","subsidiary":["OrbiMed Funds","Worldwide Healthcare Trust PLC"],"InverstorType":"基金"},{"institutionname":"Dragon Billion China Master Fund","shareholding":"2,803,800.0","percentage":4.4,"ReleaseDate":"2016-05-20 00:00:00","relatedparty":"涌金資產管理有限公司","subsidiary":["Prime Capital Funds","Dragon Billion China Master Fund"],"InverstorType":"基金"}],"TotalShareholdingPercentage":9.5},"result":1,"Version":"4.5.190802.46408","ElapsedMilliseconds":510}